Subjective cognitive decline is a better marker for future cognitive decline in females than in males

BACKGROUND: The identification of biomarkers for early detection of Alzheimer’s disease (AD) is critical to the development of therapies and interventions targeted at symptom management and tracking the pathophysiology of disease. The endorsement of subjective cognitive decline (SCD) has emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Michael D., Morrison, Cassandra, Kamal, Farooq, Graham, Jillian, Dadar, Mahsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798694/
https://www.ncbi.nlm.nih.gov/pubmed/36581949
http://dx.doi.org/10.1186/s13195-022-01138-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798694/
https://www.ncbi.nlm.nih.gov/pubmed/36581949
http://dx.doi.org/10.1186/s13195-022-01138-w

Ejemplares similares